ADC Therapeutics SA (ADCT)
NYSE: ADCT · IEX Real-Time Price · USD
3.480
-0.200 (-5.43%)
At close: Jul 2, 2024, 4:00 PM
3.460
-0.020 (-0.57%)
After-hours: Jul 2, 2024, 7:24 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $334.87 million as of July 2, 2024. Its market cap has increased by 102.09% in one year.
Market Cap
334.87M
Enterprise Value
223.48M
1-Year Change
102.09%
Ranking
Category
Stock Price
$3.48
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $1.98B to $334.87M, a decrease of -83.11%. That is a compound annual growth rate of -34.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 304.80M | 123.30% |
| Dec 29, 2023 | 136.50M | -54.65% |
| Dec 30, 2022 | 301.00M | -80.58% |
| Dec 31, 2021 | 1.55B | -31.71% |
| Dec 31, 2020 | 2.27B | 14.48% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 351.82M |
| Anavex Life Sciences | 349.57M |
| Absci | 340.95M |
| Pacific Biosciences of California | 340.47M |
| Verrica Pharmaceuticals | 335.97M |
| AxoGen | 331.72M |
| Tourmaline Bio | 330.91M |
| Foghorn Therapeutics | 320.91M |